Why Evotec SE ADR (EVO) Stock Is Rising
As of 2026-07-20, Evotec SE ADR (EVO) has a next-year EPS growth estimate of 73.22%.
Why EVO Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Evotec SE ADR's next-year EPS growth estimate from 83.88% to 83.91% on 2026-07-14.
- ·Current-Year Growth: Projected at -78.76%, supporting the forward estimate revision.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 73.22%
- EPS growth this year
- -78.76%
- EPS next quarter (est)
- -$0.04
- Last price
- $2.01
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-20 | 73.22% | -78.76% | -$0.04 | $2.01 |
| 2026-07-19 | 71.98% | -70.86% | -$0.04 | $1.96 |
| 2026-07-17 | 72.33% | -70.86% | -$0.04 | $1.96 |
| 2026-07-16 | 71.82% | -55.01% | -$0.02 | $1.97 |
| 2026-07-15 | 76.44% | -31.79% | $0.01 | $2.01 |
| 2026-07-14 | 83.91% | -20.74% | $0.01 | $2.14 |
| 2026-07-13 | 83.88% | -20.93% | $0.01 | $2.43 |
| 2026-07-12 | 83.88% | -20.93% | $0.01 | $2.79 |
| 2026-07-09 | 83.88% | -20.93% | $0.01 | $2.84 |
| 2026-07-08 | 83.88% | -20.93% | $0.01 | $2.78 |
| 2026-07-07 | 83.88% | -20.93% | $0.01 | $2.85 |
| 2026-07-06 | 83.88% | -20.93% | $0.01 | $2.92 |
| 2026-07-05 | 83.88% | -20.93% | $0.01 | $2.90 |
| 2026-07-02 | 83.88% | -20.93% | $0.01 | $2.90 |
| 2026-07-01 | 83.88% | -20.93% | $0.01 | $2.85 |
| 2026-06-30 | 83.88% | -20.93% | $0.01 | $2.80 |
| 2026-06-29 | 83.86% | -21.88% | $0.01 | $2.80 |
| 2026-06-28 | 83.86% | -21.88% | $0.01 | $2.74 |
| 2026-06-25 | 83.86% | -21.88% | $0.01 | $2.71 |
| 2026-06-24 | 83.86% | -21.88% | $0.01 | $2.69 |
| 2026-06-23 | 83.86% | -21.88% | $0.01 | $2.62 |
| 2026-06-22 | 83.86% | -21.88% | $0.01 | $2.62 |
| 2026-06-21 | 83.86% | -21.88% | $0.01 | $2.56 |
| 2026-06-18 | 83.86% | -21.88% | $0.01 | $2.56 |
| 2026-06-17 | 82.81% | -16.16% | $0.01 | $2.61 |
| 2026-06-16 | 82.81% | -16.16% | $0.01 | $2.69 |
| 2026-06-15 | 82.81% | -16.16% | $0.01 | $2.80 |
| 2026-06-14 | 82.81% | -16.16% | $0.01 | $2.72 |
| 2026-06-11 | 82.81% | -16.16% | $0.01 | $2.72 |
| 2026-06-10 | 82.81% | -16.16% | $0.01 | $2.61 |
Recent News
- Evotec SE (EVO) Q2 2026 Earnings Call Highlights: Navigating Revenue Declines and Strategic ...GuruFocus.com
- Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 OutlookPR Newswire
- Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for BiologicsPR Newswire
- Evotec Appoints Dr. Ingrid Muller as Chief Operating OfficerACCESSWIRE
- Evotec SE (EVOTF) Q4 2025 Earnings Call Highlights: Strategic Gains Amid Revenue ChallengesGuruFocus.com
- Delta Air Lines heads earnings slateMarketWatch
- What To Expect From Evotec SE (XTER:EVT) Q4 2025 EarningsGuruFocus.com
- Evotec Nominates Dieter Weinand as Supervisory Board ChairmanACCESSWIRE
Screen Performance
Aggregate stats across all 1870 tickers our top-EPS-revision screen has flagged over the past 110 days.
- Median return since detection
- +2.2%
- % of tickers in the green
- 55%
- Median return on winners
- +20.4%
- Large revisions captured
- 1056
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Evotec SE ADR (EVO) stock go up recently?▾
Evotec SE ADR (EVO) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 83.88% to 83.91% on 2026-07-14. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Evotec SE ADR's next-year EPS growth estimate?▾
As of 2026-07-20, Evotec SE ADR (EVO) has a next-year EPS growth estimate of 73.22%, based on analyst consensus.
When was the latest EPS estimate revision for EVO?▾
The most recent revision occurred on 2026-07-20, when analysts adjusted the next-year EPS growth estimate from 71.98% to 73.22%.
What sector and industry does Evotec SE ADR belong to?▾
Evotec SE ADR operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. EVO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Evotec SE ADR (EVO) appears here because it was detected by our daily top-EPS-revision-performer screen.